FOCAL CORTICAL DYSPLASIA TYPE II
Clinical trials for FOCAL CORTICAL DYSPLASIA TYPE II explained in plain language.
Never miss a new study
Get alerted when new FOCAL CORTICAL DYSPLASIA TYPE II trials appear
Sign up with your email to follow new studies for FOCAL CORTICAL DYSPLASIA TYPE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Glowing dye could help surgeons spot hidden epilepsy lesions
Disease control Not yet recruitingThis study tests whether a fluorescent dye called 5-ALA can help surgeons see and remove abnormal brain tissue in people with drug-resistant epilepsy caused by focal cortical dysplasia (FCD). FCD lesions are often hard to distinguish from healthy brain during surgery, making comp…
Matched conditions: FOCAL CORTICAL DYSPLASIA TYPE II
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill aims to tame seizures in rare brain disorders
Disease control Not yet recruitingThis early-stage trial tests an oral drug called SVG103 (Paxalisib) in 15 adults with rare brain conditions (FCD-II, TSC, or HME) that cause seizures. The main goal is to check safety and side effects, while also seeing if it reduces seizure frequency. Participants take the drug …
Matched conditions: FOCAL CORTICAL DYSPLASIA TYPE II
Phase: PHASE1, PHASE2 • Sponsor: Sovargen • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC